TWD

SMITHS FALLS, ON, May 14, 2015 /CNW Telbec/ - Tweed Marijuana Inc. ("Tweed Marijuana" or "the Company") (TSXV: TWD) and wholly owned subsidiaries Tweed Inc. (Tweed) and Tweed Farms Inc. (Tweed Farms) continue to experience an increase in demand in the medical marijuana market.

Tweed continues to engage with the medical community, over 6000 interactions to date. By promoting education in the medical community, physicians feel more comfortable incorporating marijuana in their practices, which has resulted in more Canadians choosing Tweed as their medical marijuana supplier.

The Company announced on February 18^th, 2015 that over 75,000 grams had been sold to that point in Q5, the three-month period ended March 31^st, 2015. The Company continued to experience growth and ended Q5 with over 165,000 grams sold.

"Incorporating strong medical outreach and education initiatives is a top priority for Tweed. Canadian doctors will feel increasingly confident prescribing cannabis to appropriate patients if they receive guidance and education", said Bruce Linton, Chairman and CEO of Tweed. "We are funding major research initiatives and creating accredited medical education materials that will benefit hundreds of thousands of Canadians who will use this medicine in the coming decade."

Tweed has received accreditation from the College of Family Physicians of Canada (CFPC) for a continuing medical education program.

Marijuana for Medical Purposes: The Essentials for Effective Practice was recently approved up to 1.5 Mainpro-M1 credits. The M1 designation indicates the program has demonstrated a commitment to quality educational programming and has undergone a peer-review process to ensure all content is relevant to family physicians.

More than 20,000 family physicians across Canada require Mainpro credits to maintain their CFPC membership.

Tweed will engage with the physician community in the coming weeks to outline how they can participate in this educational opportunity.

"We position our brand to be approachable to individual customers, the emphasis we place on medical outreach and education efforts extends this dialogue to include physicians. We believe we're the first Licensed Producer to offer a nationally accredited program by the CFPC, an accomplishment that will enhance our reputation within the healthcare community," said Bruce Linton.

On Monday May 11^th, Tweed joined industry partners announcing start-up funding for a research framework to allow physicians in Quebec to prescribe cannabis to their patients. Less than 3% of the market currently resides in Quebec because a clear framework did not exist in the Province. Tweed has since launched a bilingual website, offering the same rich customer experience in English and French.

Tweed has enhanced the Company's diverse strain selection by adding three new strains containing higher levels of the non-psychoactive component Cannabidiol (CBD). CBD-rich strains are sought by many patients and doctors because they do not have the same psychoactive effects of strains with higher levels of THC, the more common active ingredient associated with marijuana.

Here's to Future Growth.

About Tweed Marijuana

Tweed Marijuana Inc. is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with dual licenses under the Marihuana for Medical Purposes Regulations.

Through its wholly owned subsidiaries, Tweed Inc. and Tweed Farms Inc., Tweed Marijuana Inc. operates two state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions.

Tweed is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, and furthering the public's understanding of how marijuana is used for medical purposes.

Notice Regarding Forward Looking Statements:

This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Tweed Marijuana Inc. or Tweed Inc. to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include: (A) predictions of future demand; (B) plans to increase capital expenditure and construction related expenses; (C) anticipated production yields; (D) completion of construction and availability of new production rooms; and (E) forecasted available product selection. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Such forward-looking statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to: the ability to obtain any necessary financing; the economy generally; the yield from Tweed's marijuana growing operations; consumer interest in products; competition; regulation and anticipated and unanticipated costs and delays. Although Tweed Marijuana Inc. has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The factors identified above are not intended to represent a complete list of the factors that could affect Tweed Marijuana Inc. or Tweed Inc. Additional factors are noted under "Part IV - Description of Risk Factors Associated with the Acquisition" in the Filing Statement of Tweed Marijuana Inc. dated as of June 30, 2014 and available at www.SEDAR.com. The forward-looking statements included in this news release are made as of the date of this news release and Tweed Marijuana Inc. does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Tweed Marijuana Inc.